Clonal breadth of the HIV-1-specific T-cell receptor repertoire in vivo as determined by subtractive analysis

AIDS

Volumn 19, Issue 9, 2005, Pages 887-896

  Killian, M Scott ^a   Sabado, Rachel Lubong ^a   Kilpatrick, Stephanie ^a   Hausner, Mary Ann ^a   Jamieson, Beth D ^a   Yang, Otto O ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

5 fluorouracil; CDR3; Cytotoxic T lymphocyte; Epitope mapping; HIV 1; Spectratyping; T cell receptor

Indexed keywords

FLUOROURACIL; T LYMPHOCYTE RECEPTOR; VIRUS RECEPTOR;

ARTICLE; CELL CLONE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DELETION MUTANT; EPITOPE MAPPING; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGICAL TOLERANCE; IN VIVO STUDY; MALE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE;

EID: 20644447348     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.aids.0000171402.00372.c2     Document Type: Article

References (44)

1. Zinkernagel RM, Doherty PC. Immunological surveillance against altered self components by sensitised T lymphocytes in lymphocytic choriomeningitis. Nature 1974; 251:547-548.
2. Ahmed R, Gray D. Immunological memory and protective immunity: understanding their relation. Science 1996; 272:54-60.
3. Yang OO. Will we be able to 'spot' an effective HIV-1 vaccine? Trends Immunol 2003; 24:67-72.
4. Jin X, Bauer DE, Tuttleton SE, Lewin S, Gettie A, Blanchard J, et al. Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques. J Exp Med 1999; 189:991-998.
5. Matano T, Shibata R, Siemon C, Connors M, Lane HC, Martin MA. Administration of an anti-CD8 monoclonal antibody interferes with the clearance of chimeric simian/human immunodeficiency virus during primary infections of rhesus macaques. J Virol 1998; 72:164-169.
6. Metzner KJ, Jin X, Lee FV, Gettie A, Bauer DE, Di Mascio M, et al. Effects of in vivo CD8(+) T cell depletion on virus replication in rhesus macaques immunized with a live, attenuated simian immunodeficiency virus vaccine. J Exp Med 2000; 191:1921-1931.
7. Addo MM, Yu XG, Rathod A, Cohen D, Eldridge RL, Strick D, et al. Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load. J Virol 2003; 77:2081-2992.
8. Betts MR, Casazza JP, Koup RA. Monitoring HIV-specific CD8+ T cell responses by intracellular cytokine production. Immunol Lett 2001 ; 79:117-125.
9. Yang OO, Kalams SA, Rosenzweig M, Trocha A, Jones N, Koziel M, et al. Efficient lysis of human immunodeficiency virus type 1-infected cells by cytotoxic T lymphocytes. J Virol 1996; 70:5799-5806.
10. Yang OO, Sarkis PT, Ali A, Harlow JD, Brander C, Kalams SA, et al. Determinant of HIV-1 mutational escape from cytotoxic T lymphocytes. J Exp Med 2003; 197:1365-1375.
11. Wilson RK, Lai E, Concannon P, Earth RK, Hood LE. Structure, organization and polymorphism of murine and human T-cell receptor alpha and beta chain gene families. Immunol Rev 1988; 101:149-172.
12. Davis MM, Bjorkman PJ. T-cell antigen receptor genes and T-cell recognition. Nature 1988; 334:395-402.
13. Garcia KC, Degano M, Stanfield RL, Brunmark A, Jackson MR, Peterson PA, et al. An alphabeta T cell receptor structure at 2.5 A and its orientation in the TCR-MHC complex. Science 1996; 274:209-219.
14. Rowen L, Koop BF, Hood L. The complete 685-kilobase DNA sequence of the human beta T cell receptor locus. Science 1996; 272:1755-1762.
15. Komori T, Okada A, Stewart V, Alt FW. Lack of N regions in antigen receptor variable region genes of TdT-deficient lymphocytes. Science 1993; 261:1171-1175.
16. Brander C, Hartman KE, Trocha AK, Jones NG, Johnson RP, Korber B, et al. Lack of strong immune selection pressure by the immunodominant, HLA-A0201-restricted cytotoxic T lymphocyte response in chronic human immunodeficiency virus-1 infection. J Clin Invest 1998; 101:2559-2566.
17. Kalams SA, Johnson RP, Dynan MJ, Hartman KE, Harrer T, Harrer E, et al. T cell receptor usage and fine specificity of human immunodeficiency virus 1-specific cytotoxic T lymphocyte clones: analysis of quasispecies recognition reveals a dominant response directed against a minor in vivo variant. J Exp Med 1996; 183:1669-1679.
18. Altfeld MA, Trocha A, Eldridge RL, Rosenberg ES, Phillips MN, Addo MM, et al. Identification of dominant optimal HLA-B60- and HLA-B61-restricted cytotoxic T-lymphocyte (CTL) epitopes: rapid characterization of CTL responses by enzyme-linked immunospot assay. J Virol 2000; 74:8541-8549.
19. Douek DC, Betts MR, Brenchley JM, Hill BJ, Ambrozak DR, Ngai KL, et al. A novel approach to the analysis of specificity, clonality, and frequency of HIV-specific T cell responses reveals a potential mechanism for control of viral escape. J Immunol 2002; 168:3099-3104.
20. Brander C, Goulder PJ. HIV Molecular Immunology. 2000:111-119.
21. Killian MS, Monteiro J, Matud J, Hultin LE, Hausner MA, Yang OO, et al. Persistent alterations in the T-cell repertoires of HIV-1-infected and at-risk uninfected men. AIDS 2004; 18:161-170.
22. Wong JT, Colvin RB. Bi-specific monoclonal antibodies: selective binding and complement fixation to cells that express two different surface antigens. J Immunol 1987; 139:1369-1374.
23. Wilson CC, Wong JT, Girard DD, Merrill DP, Dynan M, An DD, et al. Ex vivo expansion of CD4 lymphocytes from human immunodeficiency virus type 1-infected persons in the presence of combination antiretroviral agents. J Infect Dis 1995; 172:88-96.
24. Yang OO, Boscardin WJ, Matud J, Hausner MA, Hultin LE, Hultin PM, et al. Immunologic profile of highly exposed yet HIV type 1-seronegative men. AIDS Res Hum Retroviruses 2002; 18:1051-1065.
25. Altman JD, Moss PA, Goulder PJ, Barouch DH, McHeyzer-Williams MG, Bell JI, et al. Phenotypic analysis of antigen-specific T lymphocytes. Science 1996; 274:94-96.
26. Ogg GS, Jin X, Bonhoeffer S, Dunbar PR, Nowak MA, Monard S, et al. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. Science 1998; 279:2103-2106.
27. Maino VC, Suni MA, Ruitenberg JJ. Rapid flow cytometric method for measuring lymphocyte subset activation. Cytometry 1995; 20:127-133.
28. Jamieson BD, Douek DC, Killian S, Hultin LE, Scripture-Adams DD, Giorgi JV, et al. Generation of functional thymocytes in the human adult. Immunity 1999; 10:569-575.
29. Gregersen PK, Hingorani R, Monteiro J. Oligoclonality in the CD8+ T-cell population: Analysis using a multiplex PCR assay for CDR3 length. Ann New York Acad Sci 1995; 756:19-27.
30. Killian MS, Matud J, Detels R, Giorgi JV, Jamieson BD. MaGiK method of T-Cell receptor repertoire analysis. Clin Diagn Lab Immunol 2002; 9:858-863.
31. Betts MR, Price DA, Brenchley JM, Lore K, Guenaga FJ, Smed-Sorensen A, et al. The functional profile of primary human antiviral CD8+ T cell effector activity is dictated by cognate peptide concentration. J Immunol 2004; 172:6407-6417.
32. Gorochov G, Neumann AU, Kereveur A, Parizot C, Li T, Katlama C, et al. Perturbation of CD4+ and CD8+ T-cell repertoires during progression to AIDS and regulation of the CD4+ repertoire during antiviral therapy. Nat Med 1998; 4:215-221.
33. Mion M, Indraccolo S, Feroli F, Minuzzo S, Masiero S, Zamarchi R, et al. TCR expression and clonality analysis in peripheral blood and lymph nodes of HIV-infected patients. Hum Immunol 1997; 57:93-103.
34. Roglic M, Macphee RD, Duncan SR, Sattler FR, Theofilopoulos AN. T cell receptor (TCR) BV gene repertoires and clonal expansions of CD4 cells in patients with HIV infections. Clin Exp Immunol 1997; 107:21-30.
35. King DJ, Larsson-Sciard EL. Clonal evolution of CD8+ T-cell expansions in HIV-infected patients on long-term HAART. Clin Exp Immunol 2001; 126:280-286.
36. Than S, Kharbanda M, Chitnis V, Bakshi S, Gregersen PK, Pahwa S. Clonal dominance patterns of CD8 T cells in relation to disease progression in HIV-infected children. J Immunol 1999;162:3680-3686.
37. Diasio RB, Harris BE. Clinical pharmacology of 5-fluorouracil. Clin Pharmacokinet 1989; 16:215-237.
38. Price DA, West SM, Betts MR, Ruff LE, Brenchley JM, Ambrozak DR, et al. T cell receptor recognition motifs govern immune escape patterns in acute SIV infection. Immunity 2004; 21:793-803.
39. Tanaka F, Fukuse T, Wada H, Fukushima M. The history, mechanism and clinical use of oral 5-fluorouracil derivative chemotherapeutic agents. Curr Pharm Biotechnol 2000; 1:137-164.
40. Walker BD, Korber BT. Immune control of HIV: the obstacles of HLA and viral diversity. Nat Immunol 2001 ; 2:473-475.
41. Goulder PJ, Tang Y, Pelton SI, Walker BD. HLA-B57-restricted cytotoxic T-lymphocyte activity in a single infected subject toward two optimal epitopes, one of which is entirely contained within the other. J Virol 2000; 74:5291-5299.
42. Jamieson BD, Yang OO, Hultin L, Hausner MA, Hultin P, Matud J, et al. Epitope escape mutation and decay of human immunodeficiency virus type 1-specific CTL responses. J Immunol 2003; 171:5372-5379.
43. O'Connor DH, Allen TM, Vogel TU, Jing P, DeSouza IP, Dodds E, et al. Acute phase cytotoxic T lymphocyte escape is a hallmark of simian immunodeficiency virus infection. Nat Med 2002; 8:493-499.
44. Brander C, Pichler WJ, Corradin G. Identification of HIV protein-derived cytotoxic T lymphocyte (CTL) epitopes for their possible use as synthetic vaccine. Clin Exp Immunol 1995; 101:107-113.